|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02192 MEDLIVE
Nominal 
9.800 +0.220 (+2.296%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 243,443 | 40.308% | 412,004 | 314,054 | 284,440 | 213,529 |
| Cost of Sales | (96,114) | 40.758% | (160,669) | (101,313) | (83,706) | (57,293) |
| Gross Profit | 147,329 | 40.016% | 251,335 | 212,741 | 200,734 | 156,236 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 5 | 12 | (2) | 0 | |
| Profit / (Loss) before Taxation | 158,148 | 54.046% | 253,132 | 135,037 | 69,927 | 104,848 | |
| Taxation | (5,442) | 442.032% | (1,372) | (8,616) | (24,682) | (19,651) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (5,987) | 103.570% | (9,459) | (9,100) | (4,629) | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 146,719 | 48.624% | 242,301 | 117,321 | 40,616 | 85,197 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (102,475) | 25.264% | (183,523) | (65,711) | (7,174) | (240) |
| Depreciation & Amortisation | -- | -- | 9,371 | 8,987 | 6,149 | 5,316 |
| Directors' Emoluments | -- | -- | 10,048 | 13,372 | 11,934 | 2,717 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 20.180 | 46.764% | 33.560 | 16.420 | 6.590 | 15.920 |
| DPS (cts) | 12.050 | -- | 23.150 | 6.540 | 1.700 | -- |
| Dividend Payout Ratio (%) | 59.713% | -- | 68.981% | 39.829% | 25.797% | -- |
| Cash flow per share ($) | -- | -- | 0.141 | 0.108 | 0.072 | 0.208 |
| NBV per share ($) | 6.439 | -- | 6.324 | 6.135 | 5.536 | -- |
| Remarks: | Real time quote last updated: 29/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 146,719,000 |
| %Change | 48.624% |
| EPS / (LPS) | RMB 0.202 |
| NBV Per Share (¥) | RMB 6.439 |